Overview

To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
A Study to Evaluate the Effects of oral repeated doses of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Ardelyx
Treatments:
Midazolam